RNZ Report Examines Menopause Information Gaps Among Asian Women

On 23 October 2026, RNZ published a report examining how stigma and limited discussion can make it harder for some Asian women in New Zealand to recognise menopause symptoms and seek medical help.

Does this report change standard menopause care?

The clinical starting point in Health New Zealand’s advice, as reported by RNZ, is individual assessment. GPs and other primary-care clinicians are usual first contacts when symptoms affect daily life. Treatment options may include lifestyle changes, non-hormonal treatments and hormone therapy according to a woman’s symptoms and circumstances.

The report does not announce a replacement for that approach. It shifts attention to an earlier question: whether women have enough understandable information and support to recognise changes and bring them into a consultation. Available care and accessible care are not the same editorial concern.

What did RNZ and the related research find?

RNZ’s reporting brought personal experiences together with clinical advice. A separate Korean study provides related evidence about menopause education needs within its own sample.

• Unexplained changes could feel frightening. Menopause coach Annu Sharma recalled anxiety, low mood and brain fog that she had not understood. Her account illustrates the uncertainty that can accompany changes without a clear explanation. She called for more research into Asian and Pacific women’s experiences and better menopause training for healthcare professionals.
• Stigma formed part of the discussion. Xian Zhang described menopause-related language being used as an insult in Chinese-language contexts. She also recalled fatigue and mood changes before her sleep worsened. She then sought advice from her GP. RNZ reported that she experienced symptom relief with menopause hormone therapy.
• The symptom picture extended beyond hot flushes. RNZ listed night sweats, fatigue, sleep disturbance and joint pain among possible symptoms. It also described anxiety and mood changes. Memory problems and difficulty concentrating were included too. The report stressed that symptoms and their effects vary among women.
• The transition can begin before periods stop. Health New Zealand guidance cited by RNZ says perimenopause may begin in the early 40s and last four to eight years. Periods may become irregular or heavier before stopping. The report described the usual confirmation of menopause as 12 consecutive months without a period.
• Daily impact was the reason to seek advice. Health New Zealand’s national clinical director Sarah Clarke advised seeking medical advice when symptoms affect quality of life or sleep. She also identified effects on work, relationships or daily activities as reasons to consult a healthcare professional. Her advice centred on the effect of changes rather than a single symptom.
• The Korean study examined specific educational needs. The 2026 study in BMC Public Health surveyed 192 community-dwelling Korean women aged 45 to 55. The sample included 123 pre/perimenopausal participants and 69 postmenopausal participants. Researchers asked them to rate perceived performance and educational need across 31 menopause-health-literacy topics.
• Educational need exceeded perceived performance throughout the survey. In both menopausal-status groups, perceived educational need was significantly higher than perceived performance on all 31 items after statistical correction. This was a comparison of participants’ own ratings. It drew attention to the gap between what women felt able to manage and what they wanted to learn.
• Priorities included cognition and finding professional help. The study identified shared priorities concerning cognitive symptoms and access to professional assistance and healthcare facilities. Prevention of psychosocial and musculoskeletal problems also featured. Some priorities differed between the pre/perimenopausal and postmenopausal groups rather than forming one identical list for everyone.

How should these findings be read?

RNZ’s report contains individual accounts and attributed advice. It is not a population survey showing how common stigma or information gaps are among Asian women in New Zealand. Those accounts concern particular people and communities within a broad and diverse category. They should not become assumptions about every Asian woman or family.

The Korean study was a cross-sectional survey within a specific age range and setting. Its self-rated findings are not an objective assessment of every participant’s knowledge. They are also not a representative estimate for New Zealand or for other populations and healthcare systems.

Zhang’s reported improvement with hormone therapy remains an individual experience rather than evidence of expected benefit for another woman. The community education ideas discussed in RNZ’s reporting are recommendations and examples, not evaluated interventions with demonstrated effects.

RNZ also cited the Ministry for Women’s Understanding Menopause publication as describing limited research among Māori, Pacific, ethnic-community and disabled women. It did not quantify that gap. Keeping personal accounts separate from survey findings and treatment evidence is part of reading menopause information critically.

What can a useful clinical conversation focus on?

Clarke’s advice offers a practical starting point: what has changed and how it affects everyday life. Sleep disruption or difficulty concentrating can be described in their own terms. A woman does not need to arrive with a settled explanation before discussing their effect on work or relationships.

That distinction matters when bringing midlife concerns into a medical conversation. Describing an experience is different from diagnosing its cause. The report supports seeking an assessment when changes are affecting life rather than deciding in advance that they are simply part of menopause.

RNZ’s account of Zhang illustrates why this matters. Her GP suspected premature ovarian insufficiency, which can cause symptoms similar to perimenopause. The relevant point is not that readers should identify with that suspected condition. It is that similar experiences may require a clinician’s assessment to understand them.

A symptom list therefore has a limited but useful role: providing language for a conversation. It is not a requirement to match every item or a reason to select a treatment independently. Personal decisions about care belong with a qualified clinician who can assess symptoms and circumstances.

Where does language support fit?

RNZ reported that menopause information was available in several languages, including simplified Chinese and Hindi. It identified Healthify and Diversity Counselling New Zealand as sources of this information. Women were also encouraged to tell their healthcare team if language support or an interpreter would help during appointments.

For someone preparing to seek care, asking about that support is a concrete option described in the report. The conversation can stay focused on communicating changes and their effect. Requesting help with language does not require the woman to have already worked out whether those changes are hormonal.

The wider editorial lesson is to distinguish information being published from information being usable. Translated material and support during a consultation address different parts of that task. Both belong in an account of access rather than being treated as secondary details after treatment options have been discussed.

What could community education address?

RNZ described a local community awareness talk covering symptoms, treatment options and wellbeing. Lily Xu spoke about community education and sharing experiences as possible ways to make discussion easier. She also proposed a multilingual helpline staffed by health professionals. That helpline was a proposal rather than an operating service identified by the report.

Sharma’s recommendations included culturally tailored community education. Read alongside the Korean study’s priorities, this points towards a useful question for future education work: does it address the subjects women say they need help understanding? Recognising cognitive changes and knowing where to find professional assistance are more specific aims than simply increasing awareness.

Community discussion need not become an expectation that every woman share personal details. A respectful editorial approach can take the reported experiences seriously without portraying an entire culture as silent. The goal should be clearer routes to reliable information and qualified care, with room for different preferences about how women participate.

What should this mean for future care?

The report’s clearest implication for future practice is to pair individual assessment with understandable information and language support, rather than leaving women solely responsible for recognising and explaining the transition.

How Refemina helps

Menopause information needs to be accessible without turning cultural differences into assumptions about every woman’s experience. Refemina separates established findings from uncertain claims so that conflicting messages about perimenopause, menopause and postmenopause are easier to assess within a broader account of midlife health.

Explore Resources

Sources

1. Nobody talks about it': Menopause stigma silences Asian women
2. link.springer.com › article › 10Priorities for menopausal health literacy-related educational ...